. . . . . . . . . . . . . . "a(CHEBI:galactosylceramide) -> p(HGNC:CD86)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "a-galactosylceramide promotes the expression of CD80/CD86 and MHC molecules on splenic DC, but CD40ligation is needed to link innate and cognate immune responses. Moreover, tumor cells loaded with a-galactosylceramide elicited potent antitumor immune protections involving CD1d-mediated cross-presentation of tumor antigens by splenic DC (Shimizu et al., 2007)." . . "Selventa" . . . . "2014-07-03T14:33:26.453+02:00"^^ . . .